Literature DB >> 21926582

Bactericidal antibiotics temporarily increase inflammation and worsen acute kidney injury in experimental sepsis.

Zhi-Yong Peng1, Hong-Zhi Wang, Nattachai Srisawat, Xiaoyan Wen, Thomas Rimmelé, Jeffery Bishop, Kai Singbartl, Raghavan Murugan, John A Kellum.   

Abstract

OBJECTIVE: To explore the relationships among bactericidal antimicrobial treatment of sepsis, inflammatory response, severity of acute kidney injury, and outcomes.
DESIGN: Controlled laboratory experiment.
SETTING: University laboratory.
INTERVENTIONS: Sepsis was induced by cecal ligation and puncture in 52 rats and was treated with either bactericidal antibiotics (ampicillin/sulbactam) or placebo (saline). Serial blood specimens were obtained after cecal ligation and puncture for serum creatinine, interleukin-6, and neutrophil gelatinase-associated lipocalin concentrations. RIFLE (Risk, Injury, Failure, Loss, End-stage kidney disease) criteria were used to assess severity of acute kidney injury. All animals were observed for survival up to 1 wk. In a separate experiment, six healthy animals were given antibiotics and renal function was assessed. Another 12 animals were euthanized 2 days after laparotomy for kidney histology.
MEASUREMENTS AND MAIN RESULTS: Survival in the placebo group was 50% compared with 81.8% in the antibiotic group (p < .05). Most animals (93%) without antibiotics developed acute kidney injury, of which 39% exhibited greater than a threefold rise in serum creatinine (RIFLE-F). Furthermore, survival decreased as acute kidney injury severity increased. Surprisingly, all antibiotic-treated animals developed acute kidney injury, of which 68.6% reached RIFLE-F. However, renal dysfunction was less persistent in these animals. Patterns of plasma interleukin-6 were similar to creatinine with higher concentrations seen earlier in antibiotic-treated animals but with faster resolution. Interleukin-6 concentration at 24 hrs was independently associated with the development of RIFLE-F. Histologic findings were consistent with functional parameters showing that antibiotics worsened acute kidney injury.
CONCLUSION: In polymicrobial sepsis, bactericidal antibiotics resulted in more inflammation and more severe acute kidney injury. However, resolution of inflammation and acute kidney injury was faster with antibiotics and correlated best with survival. These results suggest that transient worsening of renal function may be an expected consequence of sepsis therapy. These findings also question the value of peak severity of acute kidney injury as a primary end point and suggest that resolution of acute kidney injury may be more appropriate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21926582      PMCID: PMC3254710          DOI: 10.1097/CCM.0b013e31822f0d2e

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  35 in total

Review 1.  Cecal ligation and puncture.

Authors:  William J Hubbard; Mashkoor Choudhry; Martin G Schwacha; Jeffrey D Kerby; Loring W Rue; Kirby I Bland; Irshad H Chaudry
Journal:  Shock       Date:  2005-12       Impact factor: 3.454

Review 2.  Interleukin-6.

Authors:  Mingchen Song; John A Kellum
Journal:  Crit Care Med       Date:  2005-12       Impact factor: 7.598

Review 3.  The significance of endotoxin release in experimental and clinical sepsis in surgical patients--evidence for antibiotic-induced endotoxin release?

Authors:  R G Holzheimer
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

Review 4.  Immunomodulating effects of antibiotics: literature review.

Authors:  B Van Vlem; R Vanholder; P De Paepe; D Vogelaers; S Ringoir
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

5.  Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels.

Authors:  Dinesh Vyas; Pardis Javadi; Peter J Dipasco; Timothy G Buchman; Richard S Hotchkiss; Craig M Coopersmith
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-06-09       Impact factor: 3.619

6.  Acute renal failure in critically ill patients: a multinational, multicenter study.

Authors:  Shigehiko Uchino; John A Kellum; Rinaldo Bellomo; Gordon S Doig; Hiroshi Morimatsu; Stanislao Morgera; Miet Schetz; Ian Tan; Catherine Bouman; Ettiene Macedo; Noel Gibney; Ashita Tolwani; Claudio Ronco
Journal:  JAMA       Date:  2005-08-17       Impact factor: 56.272

Review 7.  A systematic review of urinary findings in experimental septic acute renal failure.

Authors:  Sean M Bagshaw; Christoph Langenberg; Li Wan; Clive N May; Rinaldo Bellomo
Journal:  Crit Care Med       Date:  2007-06       Impact factor: 7.598

8.  Variable major lipoprotein is a principal TNF-inducing factor of louse-borne relapsing fever.

Authors:  V Vidal; I G Scragg; S J Cutler; K A Rockett; D Fekade; D A Warrell; D J Wright; D Kwiatkowski
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

9.  Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release.

Authors:  C Van Den Berg; A J de Neeling; C S Schot; W N Hustinx; J Wemer; D J de Wildt
Journal:  Scand J Infect Dis       Date:  1992

10.  Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis.

Authors:  Jose Garnacho-Montero; Teresa Aldabo-Pallas; Carmen Garnacho-Montero; Aurelio Cayuela; Rocio Jiménez; Sonia Barroso; Carlos Ortiz-Leyba
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

View more
  26 in total

1.  Effects of hemoadsorption with a novel adsorbent on sepsis: in vivo and in vitro study.

Authors:  Jicheng Zhang; Zhiyong Peng; Donald Maberry; Jacob Volpe; Jeremy D Kimmel; William J Federspiel; John A Kellum
Journal:  Blood Purif       Date:  2015-04-01       Impact factor: 2.614

2.  Emergence of Burkholderia cepacia in Honolulu: a case of nursing home-acquired B. cepacia sepsis.

Authors:  Charles Nc Hua; Jinichi Tokeshi
Journal:  Hawaii J Med Public Health       Date:  2013-09

3.  Effect of empiric antibiotic treatment on plasma endotoxin activity in septic patients.

Authors:  F Mignon; M Piagnerelli; M Van Nuffelen; J L Vincent
Journal:  Infection       Date:  2014-01-28       Impact factor: 3.553

4.  How can antibiotics worsen acute kidney injury but improve survival in experimental sepsis?.

Authors:  Ana C P Souza; Peter S T Yuen
Journal:  Crit Care Med       Date:  2012-02       Impact factor: 7.598

5.  Effects of fluid resuscitation with 0.9% saline versus a balanced electrolyte solution on acute kidney injury in a rat model of sepsis*.

Authors:  Feihu Zhou; Zhi-Yong Peng; Jeffery V Bishop; Matthew E Cove; Kai Singbartl; John A Kellum
Journal:  Crit Care Med       Date:  2014-04       Impact factor: 7.598

6.  One dose of cyclosporine A is protective at initiation of folic acid-induced acute kidney injury in mice.

Authors:  Xiaoyan Wen; Zhiyong Peng; Yingjian Li; Hongzhi Wang; Jeffrey V Bishop; Lisa R Chedwick; Kai Singbartl; John A Kellum
Journal:  Nephrol Dial Transplant       Date:  2012-01-31       Impact factor: 5.992

Review 7.  The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.

Authors:  Sarah A Sterling; W Ryan Miller; Jason Pryor; Michael A Puskarich; Alan E Jones
Journal:  Crit Care Med       Date:  2015-09       Impact factor: 7.598

Review 8.  Evaluation of vitamin C for adjuvant sepsis therapy.

Authors:  John X Wilson
Journal:  Antioxid Redox Signal       Date:  2013-06-25       Impact factor: 8.401

Review 9.  Subclinical AKI--an emerging syndrome with important consequences.

Authors:  Michael Haase; John A Kellum; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2012-09-25       Impact factor: 28.314

Review 10.  Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.

Authors:  Alexandre Boyer; Didier Gruson; Stéphane Bouchet; Benjamin Clouzeau; Bui Hoang-Nam; Frédéric Vargas; Hilbert Gilles; Mathieu Molimard; Anne-Marie Rogues; Nicholas Moore
Journal:  Drug Saf       Date:  2013-04       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.